CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-08-06 | Bahcall Safi R President and CEO | Purchase | +196 | $2.88 | $564 | 2,261,280 |
| 2009-08-06 | Bahcall Safi R President and CEO | Purchase | +9,245 | $2.89 | $27K | 2,270,525 |
| 2009-07-01 | Gollust Keith R Director | Grant or award | +16,806 | 64,079 | ||
| 2009-07-01 | Gollust Keith R Director | Grant or award · Director Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2009-07-01 | Gollust Keith R Director | Grant or award · Director Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2009-07-01 | Kovner Bruce Director | Grant or award | +16,806 | 950,673 | ||
| 2009-07-01 | Kovner Bruce Director | Grant or award · Director Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2009-07-01 | REARDON WILLIAM S Director | Grant or award | +4,201 | 8,376 | ||
| 2009-07-01 | REARDON WILLIAM S Director | Grant or award · Director Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2009-07-01 | WILSON ROBERT N Director | Grant or award | +8,403 | 364,677 | ||
| 2009-07-01 | WILSON ROBERT N Director | Grant or award · Director Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2009-04-13 | Rieder Wendy E VP, IP and Legal, Gen. Counsel | Grant or award · Employee Stock Option (Right to Buy) | +30,870 | 30,870 | ||
| 2009-04-13 | Ehrlich Keith S VP, Fin. and Admin., CFO | Grant or award · Employee Stock Option (Right to Buy) | +30,870 | 30,870 | ||
| 2009-04-13 | Koya Keizo Sr. VP, Drug Development | Grant or award · Employee Stock Option (Right to Buy) | +44,616 | 44,616 | ||
| 2009-04-13 | Jacobson Eric W Sr. VP, Research and CMO | Grant or award · Employee Stock Option (Right to Buy) | +47,112 | 47,112 | ||
| 2009-04-13 | Chadwick Jeremy G Sr. VP, Pgm Mgmt and Clin Ops | Grant or award · Employee Stock Option (Right to Buy) | +42,900 | 42,900 | ||
| 2009-04-13 | Barsoum James G Sr. VP, Research | Grant or award · Employee Stock Option (Right to Buy) | +42,900 | 42,900 | ||
| 2009-04-13 | BAILEY MICHAEL P Sr. VP, Chief Comm. Officer | Grant or award · Employee Stock Option (Right to Buy) | +46,800 | 46,800 | ||
| 2009-04-13 | Bahcall Safi R President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +146,300 | 146,300 | ||
| 2009-01-05 | Chadwick Jeremy G Sr. VP, Pgm Mgmt and Clin Ops | Sale | −4,573 | $6.20 | $28K | 15,853 |
Page 78 of 82 · 1,629 trades